Eisai Receives Positive Opinion from the CHMP in the European Union for Lecanemab in Early Alzheimer’s Disease
1. About lecanemab (generic name, brand name: Leqembi®) Lecanemab is the result of a strategic research alliance between Eisai and BioArctic. It is a humanized immunoglobulin gamma 1 (IgG1) monoclonal ...
Armed robbery in Revesby4h
Record 20M New Business Applications Filed
The Biden-Harris Administration has powered a small business boom, overseeing record growth and support for small businesses across the countrySince ...
Armed robbery in Revesby4h
Concerns Over National Registration Scheme Complexity
We have long advocated for the establishment of a national Independent Health Workforce Planning and Analysis Agency to ...
Pharmabiz13h
Islamic Development Bank joins efforts with WHO and development partners to promote health impact investment
Islamic Development Bank joins efforts with WHO and development partners to promote health impact investment: Geneva Thursday, November 14, 2024, 12:00 Hrs [IST] As part of its co ...
The Business Journals20h
Health Care Innovation Awards: Central City Concern
Portland’s biggest homeless services provider attempts to solve the problem of caring for a highly mobile, in-need population ...